US64125C1099
Impact Score
Neurocrine Biosciences, Inc. is a biotech firm specializing in neurologic, endocrine, and psychiatric disorders. They focus on drug discovery and development.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
Kevin C. Gorman, | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 3 | |||
58 | ratio | 2023 | 2023Annual-Report.pdf | 72 | ||
Employee turnover rate | ||||||
5,6 | % | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 31 | ||
Glass Ceiling | ||||||
53 | % | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 18 | ||
48 | % | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 18 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 28 | |||
Yes | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 28 | |||
Yes | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 17 | |||
Yes | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 28 | |||
Recycling and Recovery of Waste | ||||||
73 075 | LBS | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 24 | ||
73 560 | LBS | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 24 | ||
Women on the Board | ||||||
40 | % | 2023 | 2023Annual-Report.pdf | 19 | ||
Women in Management | ||||||
48 | % | 2023 | Neurocrine_2024-CSR-Report_04.10.24_Final.pdf | 18 |